logo
Plus   Neg
Share
Email

EARNINGS SUMMARY: Details of Biomarin Pharmaceutical Inc. Q2 Earnings Report

Below are the earnings highlights for Biomarin Pharmaceutical Inc. (BMRN):

-Earnings: -$37.4 million in Q2 vs. -$16.8 million in the same period last year.
-EPS: -$0.21 in Q2 vs. -$0.09 in the same period last year.
-Analysts projected -$0.10 per share
-Revenue: $387.8 million in Q2 vs. $372.8 million in the same period last year.

-Guidance:
Full year revenue guidance: $1.68 - $1.75 Bln

For comments and feedback contact: editorial@rttnews.com

Follow RTT